Cargando…
Permissive hypofiltration
Acute kidney injury (AKI) is a syndrome with a multitude of causes and is associated with high mortality and a permanent loss of renal function. Our current understanding of the most common causes of AKI is limited, and thus a silver bullet therapy remains elusive. A change in the approach to AKI th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580674/ https://www.ncbi.nlm.nih.gov/pubmed/22839207 http://dx.doi.org/10.1186/cc11253 |
_version_ | 1782260304751624192 |
---|---|
author | Chawla, Lakhmir S Kellum, John A Ronco, Claudio |
author_facet | Chawla, Lakhmir S Kellum, John A Ronco, Claudio |
author_sort | Chawla, Lakhmir S |
collection | PubMed |
description | Acute kidney injury (AKI) is a syndrome with a multitude of causes and is associated with high mortality and a permanent loss of renal function. Our current understanding of the most common causes of AKI is limited, and thus a silver bullet therapy remains elusive. A change in the approach to AKI that shifts away from the primary composite endpoint of death/dialysis, and instead focuses on improving survival and mitigating permanent renal damage, is likely to be more fruitful. We suggest that the current approach of augmenting renal function by increasing the renal blood flow or glomerular filtration rate during AKI may actually worsen outcomes. Analogous to the approach towards adult respiratory distress syndrome that limits ventilator-induced lung injury, we propose the concept of permissive hypofiltration. The primary goals of this approach are: resting the kidney by providing early renal replacement therapy, avoiding the potentially injurious adverse events that occur during AKI (for example, fluid overload, hypophosphatemia, hypothermia, and so forth), and initiating therapies focused on improving survival and mitigating permanent loss of kidney function. |
format | Online Article Text |
id | pubmed-3580674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35806742013-07-26 Permissive hypofiltration Chawla, Lakhmir S Kellum, John A Ronco, Claudio Crit Care Viewpoint Acute kidney injury (AKI) is a syndrome with a multitude of causes and is associated with high mortality and a permanent loss of renal function. Our current understanding of the most common causes of AKI is limited, and thus a silver bullet therapy remains elusive. A change in the approach to AKI that shifts away from the primary composite endpoint of death/dialysis, and instead focuses on improving survival and mitigating permanent renal damage, is likely to be more fruitful. We suggest that the current approach of augmenting renal function by increasing the renal blood flow or glomerular filtration rate during AKI may actually worsen outcomes. Analogous to the approach towards adult respiratory distress syndrome that limits ventilator-induced lung injury, we propose the concept of permissive hypofiltration. The primary goals of this approach are: resting the kidney by providing early renal replacement therapy, avoiding the potentially injurious adverse events that occur during AKI (for example, fluid overload, hypophosphatemia, hypothermia, and so forth), and initiating therapies focused on improving survival and mitigating permanent loss of kidney function. BioMed Central 2012 2012-07-26 /pmc/articles/PMC3580674/ /pubmed/22839207 http://dx.doi.org/10.1186/cc11253 Text en Copyright ©2012 BioMed Central Ltd |
spellingShingle | Viewpoint Chawla, Lakhmir S Kellum, John A Ronco, Claudio Permissive hypofiltration |
title | Permissive hypofiltration |
title_full | Permissive hypofiltration |
title_fullStr | Permissive hypofiltration |
title_full_unstemmed | Permissive hypofiltration |
title_short | Permissive hypofiltration |
title_sort | permissive hypofiltration |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580674/ https://www.ncbi.nlm.nih.gov/pubmed/22839207 http://dx.doi.org/10.1186/cc11253 |
work_keys_str_mv | AT chawlalakhmirs permissivehypofiltration AT kellumjohna permissivehypofiltration AT roncoclaudio permissivehypofiltration |